Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2020-08-13, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CPHI/20200813/10-Q/1/000.htm SEC Original: f10q0620_chinapharmaholdings.htm

---

---

Webplus: CPHI/20200813/10-Q/2_EX-31.1/000.htm SEC Original: f10q0620ex31-1_chinapharma.htm
CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: CPHI/20200813/10-Q/3_EX-31.2/000.htm SEC Original: f10q0620ex31-2_chinapharma.htm
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,

---

---

Webplus: CPHI/20200813/10-Q/4_EX-32.1/000.htm SEC Original: f10q0620ex32-1_chinapharma.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 13, 2020 President and Chief Executive Officer accounting officer) (principal financial officer and principal EX-32.1 4 f10q0620ex32-1_chinapharma.htm CERTIFICATION

---

Company Info:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2020-08-13, XBRL Interactive FinancialsCIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216